Skip to content
Home/Companies/Pharma/Provell Pharmaceuticals

Provell Pharmaceuticals

Pharma·United States·Exited 2025·Held 12yr
Entry
2013
Hold
12yr
Exit
2025

Who owns Provell Pharmaceuticals?

Provell Pharmaceuticals is an American Pharma company, formerly owned by Flerie, exited in 2025. No current private equity owner is on file.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Flerie
Investor
Flerie
Flerie Invest · 2011 · Life Sciences VC

Key facts

HQUnited States
SectorPharma
StatusAcquired
Exit Year
2025

More from Flerie Invest

Other portfolio companies in the same fund.

Frontier Biosolutions
Active
PharmaGermany· 2023
Mendus
Active
BiotechSweden· 2023
A3P Biomedical
Exited 2025
BiotechSweden· 2022
Alder Therapeutics
Active
BiotechSweden· 2022
AnaCardio
Active
BiotechSweden· 2022
Bohus Biotech
Active
PharmaSweden· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Provell Pharmaceuticals?

Provell Pharmaceuticals was formerly owned by Flerie, exited in 2025. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue